Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Another China Bribery Rumor Involving Novartis

publication date: Sep 20, 2013
Novartis has a novel scandal potentially brewing in China: a whistleblower with the colorful alias “Zorro,” alleges that Alcon, the eyecare unit of Novartis, bribed doctors in 200 hospitals using money intended for post-marketing patient experience surveys of lens implants. The surveys are a form of post-approval clinical trial. One month ago, a China salesperson went public with a claim that her manager ordered her to use $8,170 so that she could meet her revenue targets. More details....

Stock Symbol: (NYSE: NVS)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital